HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)
CNY 8.18
(-5.43%)
CNY 8.18
(-5.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 332.98 Million | 307.32 Million | -233 Million | -9.22 Million | -411.6 Million | 366.45 Million |
| Net Income | 292.16 Million | 263.4 Million | 276.51 Million | 144.95 Million | 267.3 Million | 257.85 Million |
| Depreciation & Amortization | 62.45 Million | 63.99 Million | 60.43 Million | 24.9 Million | 47.62 Million | 29.47 Million |
| Deferred income taxes | -5.58 Million | 2.97 Million | -1.91 Million | -4.74 Million | -5.78 Million | 4.71 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -69.28 Million | -41.13 Million | -603.92 Million | -204.83 Million | -750.71 Million | 81.89 Million |
| Other non-cash items | 247.43 Million | 21.05 Million | 33.96 Million | 25.75 Million | 24.18 Million | -2.77 Million |
| Investing Cash Flow | -179.85 Million | -5.86 Million | -11.54 Million | -12.67 Million | -8.15 Million | -5.01 Million |
| Investments in PPE | -23.48 Million | -6.41 Million | -12.24 Million | -13.96 Million | -8.33 Million | -5.73 Million |
| Acquisitions | 263.34 Thousand | 549.44 Thousand | 693.28 Thousand | 1.27 Million | 179.24 Thousand | 716.34 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -156.63 Million | 0.66 | 0.35 | 21.79 Thousand | 0.03 | 716.34 Thousand |
| Financing Cash Flow | 117.85 Million | 149.51 Million | 342.31 Million | 71.5 Million | 281.26 Million | -299.01 Million |
| Debt repayment | -236.07 Million | -1.29 Billion | -699 Million | -524 Million | -334 Million | -224 Million |
| Dividends payments | -24.62 Million | -30.48 Million | -69.58 Million | -4.25 Million | -14.16 Million | -299.01 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 378.54 Million | 1.47 Billion | 1.07 Billion | 599.76 Million | 629.42 Million | 224 Million |
| Accounts receivables | -228.87 Million | 699.59 Thousand | -292.95 Million | -435.16 Million | -1.01 Billion | 365.7 Million |
| Accounts payables | 201 Million | -76.02 Million | -326.39 Million | 213.1 Million | 560.01 Million | -374.39 Million |
| Inventory | -41.41 Million | 31.22 Million | 17.34 Million | 21.96 Million | -292.34 Million | 85.87 Million |
| Other working capital | 195.41 Million | 2.97 Million | -1.91 Million | -4.74 Million | -5.78 Million | -3.97 Million |
| Cash at beginning of period | 1.18 Billion | 514.57 Million | 416.81 Million | 367.2 Million | 505.69 Million | 443.28 Million |
| Cash at end of period | 1.31 Billion | 965.54 Million | 514.57 Million | 416.81 Million | 367.2 Million | 505.69 Million |
| Capital Expenditure | -23.48 Million | -6.41 Million | -12.24 Million | -13.96 Million | -8.33 Million | -5.73 Million |
| Effect of forex changes on cash | -138.1 Million | - | - | 0.72 | - | - |
| Net cash flow / Change in cash | 132.87 Million | 450.97 Million | 97.75 Million | 49.61 Million | -138.49 Million | 62.41 Million |
| Free Cash Flow | 309.5 Million | 300.9 Million | -245.24 Million | -23.19 Million | -419.93 Million | 360.71 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 70.81 Million | 56.85 Million | 78.33 Million | 51.62 Million | 292.16 Million | 87.19 Million |
| Depreciation & Amortization | - | 15.5 Million | 15.5 Million | 15.43 Million | 62.45 Million | -29.89 Million |
| Deferred income taxes | - | - | - | - | -5.58 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -68.86 Million | - | -270.28 Million | -69.28 Million | 325.29 Million |
| Other non-cash items | -108.91 Million | 89.75 Million | -414.63 Million | 380.67 Million | 247.43 Million | -492.69 Million |
| Investing Cash Flow | -985.45 Thousand | -2.04 Million | -1.13 Million | -19.23 Million | -179.85 Million | -157.71 Million |
| Investments in PPE | -1.02 Million | -2.12 Million | -1.13 Million | -19.29 Million | -23.48 Million | -1.14 Million |
| Acquisitions | 43.2 Thousand | 80.82 Thousand | - | 51 Thousand | 263.34 Thousand | 69 Thousand |
| Investment purchases | - | - | - | - | - | -567 Thousand |
| Sales/Maturities of investments | - | - | - | -498 Thousand | - | 498 Thousand |
| Other Investing Activities | 43.2 Thousand | 80.82 Thousand | - | 498 Thousand | -156.63 Million | -156.56 Million |
| Financing Cash Flow | -235.68 Million | -150.17 Million | 130.77 Million | 129.55 Million | 117.85 Million | 11.22 Million |
| Debt repayment | -137.8 Million | -80 Million | -150 Million | -226.07 Million | -236.07 Million | -217.8 Million |
| Dividends payments | -87.29 Million | -58.2 Million | -5.28 Million | -6.13 Million | -24.62 Million | -5.11 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -10.58 Million | -44.25 Million | -19.22 Million | 361.75 Million | 378.54 Million | 234.14 Million |
| Accounts receivables | - | -109.55 Million | - | -228.87 Million | -228.87 Million | 382.71 Million |
| Accounts payables | - | - | - | - | 201 Million | - |
| Inventory | - | 40.69 Million | - | -41.41 Million | -41.41 Million | -57.42 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1 Billion | 1.05 Billion | 1.31 Billion | 1 Billion | 1.18 Billion | 1.2 Billion |
| Cash at end of period | 733.99 Million | 1.01 Billion | 1.05 Billion | 1.31 Billion | 1.31 Billion | 948.78 Million |
| Capital Expenditure | -1.02 Million | -2.12 Million | -1.13 Million | -19.29 Million | -23.48 Million | -1.14 Million |
| Effect of forex changes on cash | - | - | -18.44 Thousand | 18.72 Million | -138.1 Million | -0.08 |
| Net cash flow / Change in cash | -274.77 Million | -36.8 Million | -260 Million | 306.47 Million | 132.87 Million | -256.58 Million |
| Free Cash Flow | -39.13 Million | 128.98 Million | -337.42 Million | 158.14 Million | 309.5 Million | -111.24 Million |
PMMP
000230
DGN
600216
FLEW
GAME